These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2126497)

  • 21. Resistance of Trypanosoma cruzi to killing by macrophages.
    Kress Y; Bloom BR; Wittner M; Rowen A; Tanowitz H
    Nature; 1975 Oct; 257(5525):394-6. PubMed ID: 809716
    [No Abstract]   [Full Text] [Related]  

  • 22. Pleiotropic effects of cytokines: clinical and preclinical studies.
    Bukowski RM; Olencki T; McLain D; Finke JH
    Stem Cells; 1994; 12 Suppl 1():129-40; discussion 140-1. PubMed ID: 7696957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic colony-stimulating factors.
    Andreeff M; Welte K
    Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
    [No Abstract]   [Full Text] [Related]  

  • 24. The colony-stimulating factors.
    Henderson G
    Aust Nurses J; 1991 Mar; 20(7):27-8. PubMed ID: 2049007
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin 3 perfusion prevents death due to acute anemia induced by monoclonal antierythrocyte autoantibody.
    Shibata T; Kindler V; Chicheportiche Y; Vassalli P; Izui S
    J Exp Med; 1990 May; 171(5):1809-14. PubMed ID: 2185334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
    Willemse PH; Boonstra H; de Vries EG
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450
    [No Abstract]   [Full Text] [Related]  

  • 27. From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics.
    Teh-Poot C; Tzec-Arjona E; Martínez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Dumonteil E
    J Infect Dis; 2015 Jan; 211(2):258-66. PubMed ID: 25070943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-3 in combination with granulocyte-macrophage-colony-stimulating factor following bone marrow transplantation in a radiation accident victim.
    Nagler A; Naparstek E; Drakos P; Brautbar C; Goldman M; Kaplan O; Fridmann A; Slavin S
    Med Oncol; 1994; 11(1):27-8. PubMed ID: 7921925
    [No Abstract]   [Full Text] [Related]  

  • 29. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3.
    Feng ZY; Louis J; Kindler V; Pedrazzini T; Eliason JF; Behin R; Vassalli P
    Eur J Immunol; 1988 Aug; 18(8):1245-51. PubMed ID: 2970970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.
    Reed SG; Nathan CF; Pihl DL; Rodricks P; Shanebeck K; Conlon PJ; Grabstein KH
    J Exp Med; 1987 Dec; 166(6):1734-46. PubMed ID: 3119762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice.
    Araujo Z; Heremans H; Stordeur P; Wissing M; Goldman M; Castes M; Carlier Y
    Vaccine; 2000 Mar; 18(17):1822-9. PubMed ID: 10699330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.
    Grau GE; Kindler V; Piguet PF; Lambert PH; Vassalli P
    J Exp Med; 1988 Oct; 168(4):1499-504. PubMed ID: 3049913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF).
    Garnick MB; Stoudemire JB
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():356-71; discussion 371-3. PubMed ID: 2182744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of granulocyte-macrophage colony-stimulating factor in the pathogenesis of experimental murine leishmaniasis.
    Solbach W; Bodendorfer B; Greil J; Röllinghoff M
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():407-10. PubMed ID: 3075683
    [No Abstract]   [Full Text] [Related]  

  • 36. Use and toxicity of the colony-stimulating factors.
    Schriber JR; Negrin RS
    Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection.
    Rottenberg ME; Cardoni RL; Sinagra A; Riarte A; Rodriguez Nantes I; Lauricella M; Segura EL
    Exp Parasitol; 1991 Aug; 73(2):127-36. PubMed ID: 1909649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
    Arellano M; K Waller E
    Curr Hematol Rep; 2004 Nov; 3(6):424-31. PubMed ID: 15496276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
    Chelstrom LM; Finnegan D; Uckun FM
    Leuk Lymphoma; 1992 May; 7(1-2):79-86. PubMed ID: 1282065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
    Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
    Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.